Of note, low expression of IGF1 is an important contributor to increased susceptibility of these relevant pathways during the development of AD, giving rise to subsequent impaired Aβ clearance and neuronal apoptosis [59–61]. This evidence concerns the gene IGF1 and Alzheimer disease.